{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:54:25Z","timestamp":1788314065974,"version":"build-2803163510"},"reference-count":69,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["HD056235, HD091639 to KG, P30NS048154"],"award-info":[{"award-number":["HD056235, HD091639 to KG, P30NS048154"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Down syndrome (DS), trisomy of the long arm of human chromosome 21 (Hsa21), is the most common genetic cause of intellectual disability (ID). Currently, there are no effective pharmacotherapies. The success of clinical trials to improve cognition depends in part on the design of preclinical evaluations in mouse models. To broaden understanding of the common limitations of experiments in learning and memory, we report performance in context fear conditioning (CFC) in three mouse models of DS, the Dp(16)1Yey, Dp(17)1Yey and Dp(10)1Yey (abbreviated Dp16, Dp17 and Dp10), separately trisomic for the human Hsa21 orthologs mapping to mouse chromosomes 16, 17 and 10, respectively. We examined female and male mice of the three lines on the standard C57BL\/6J background at 3 months of age and Dp17 and Dp10 at 18 months of age. We also examined female and male mice of Dp17 and Dp10 at 3 months of age as F1 hybrids obtained from a cross with the DBA\/2J background. Results indicate that genotype, sex, age and genetic background affect CFC performance. These data support the need to use both female and male mice, trisomy of sets of all Hsa21 orthologs, and additional ages and genetic backgrounds to improve the reliability of preclinical evaluations of drugs for ID in DS.<\/jats:p>","DOI":"10.3390\/genes12101528","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T12:29:14Z","timestamp":1632832154000},"page":"1528","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Context Fear Conditioning in Down Syndrome Mouse Models: Effects of Trisomic Gene Content, Age, Sex and Genetic Background"],"prefix":"10.3390","volume":"12","author":[{"given":"Md. Mahiuddin","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Neurology, Linda Crnic Institute for Down Syndrome, University of Colorado Alzheimer\u2019s and Cognition Center, Aurora, CO 80045, USA"},{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Block","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Busquet","sequence":"additional","affiliation":[{"name":"Department of Neurology, Animal Behavior and In Vivo Neurophysiology Core, NeuroTechnology Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katheleen J.","family":"Gardiner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P","article-title":"Behavioral phenotype of individuals with Down syndrome","volume":"6","author":"Chapman","year":"2000","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/mrdd.20156","article-title":"Down syndrome: Cognitive phenotype","volume":"13","author":"Silverman","year":"2007","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_3","unstructured":"Centers for Disease Control and Prevention (CDC) (2006). Improved National Prevalence Estimates for 18 Major Birth Defects, Morbidity and Mortality Weekly Report."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ejhg.2008.122","article-title":"Twenty-year trends in prevalence and survival of Down syndrome","volume":"16","author":"Irving","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":"Updated national birth prevalence estimates for selected birth defects in the United States, 2004\u20132006","volume":"88","author":"Parker","year":"2010","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1034\/j.1399-0004.2002.620506.x","article-title":"The changing survival profile of people with Down\u2019s syndrome: Implications for genetic counselling","volume":"62","author":"Glasson","year":"2002","journal-title":"Clin. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1469-8749.2004.tb00483.x","article-title":"Clinical, social, and ethical implications of changing life expectancy in Down syndrome","volume":"46","author":"Bittles","year":"2007","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","article-title":"The four ages of Down syndrome","volume":"17","author":"Bittles","year":"2006","journal-title":"Eur. J. Public Heal."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1542\/peds.2012-1616","article-title":"Congenital Anomaly Multistate Prevalence and Survival Collaborative Trends in survival among children with Down syndrome in 10 regions of the United States","volume":"131","author":"Kucik","year":"2013","journal-title":"Pediatrics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2015.10.083","article-title":"Improved Survival in Down Syndrome over the Last 60 Years and the Impact of Perinatal Factors in Recent Decades","volume":"169","author":"Glasson","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States","volume":"19","author":"Buckley","year":"2017","journal-title":"Genet. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/ajmg.a.38465","article-title":"Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date","volume":"173","author":"Hart","year":"2017","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"TESDAD study group. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down\u2019s syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Hernandez","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1038\/tp.2012.66","article-title":"Antagonism of NMDA receptors as a potential treatment for Down syndrome: A pilot randomized controlled trial","volume":"2","author":"Boada","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/DDDT.S51476","article-title":"Pharmacological approaches to improving cognitive function in Down syndrome: Current status and con-siderations","volume":"9","author":"Gardiner","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1073\/pnas.86.15.5958","article-title":"Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome","volume":"86","author":"Rahmani","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000472398","article-title":"Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21","volume":"1","author":"Delabar","year":"1993","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1073\/pnas.91.11.4997","article-title":"Down syndrome phenotypes: The consequences of chromosomal imbalance","volume":"91","author":"Korenberg","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1073\/pnas.0813248106","article-title":"The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies","volume":"106","author":"Korbel","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","article-title":"Mouse models of Down syndrome: Gene content and consequences","volume":"27","author":"Gupta","year":"2016","journal-title":"Mamm. Genome"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tig.2020.09.017","article-title":"All Creatures Great and Small: New Approaches for Understanding Down Syndrome Genetics","volume":"37","author":"Moyer","year":"2020","journal-title":"Trends Genet."},{"key":"ref_23","first-page":"263","article-title":"Segmental trisomy of murine chromosome 16: A new model system for studying Down syndrome","volume":"360","author":"Davisson","year":"1990","journal-title":"Prog. Clin. Boil. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fnbeh.2015.00268","article-title":"Dissecting Alzheimer disease in Down syndrome using mouse models","volume":"9","author":"Choong","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Rueda, N., Fl\u00f3rez, J., and Mart\u00ednez-Cu\u00e9, C. (2012). Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities. Neural Plast., 584071.","DOI":"10.1155\/2012\/584071"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: Impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.pbr.2019.08.001","article-title":"Modeling Down syndrome in animals from the early stage to the 4.0 models and next","volume":"251","author":"Moreno","year":"2019","journal-title":"Prog Brain Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e56223","DOI":"10.7554\/eLife.56223","article-title":"A non-mosaic transchromosomic mouse model of down syn-drome carrying the long arm of human chromosome 21","volume":"9","author":"Kazuki","year":"2020","journal-title":"Elife"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_30","first-page":"117","article-title":"Segmental trisomy as a mouse model for Down syndrome","volume":"384","author":"Davisson","year":"1993","journal-title":"Prog. Clin. Boil. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","article-title":"Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: Relevance for modeling down syndrome","volume":"22","author":"Duchon","year":"2011","journal-title":"Mamm. Genome"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1523\/JNEUROSCI.1203-12.2013","article-title":"Reducing GABAA \u03b15 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome","volume":"33","author":"Rueda","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00335-010-9300-8","article-title":"Increased male reproductive success in Ts65Dn \u201cDown syndrome\u201d mice","volume":"21","author":"Moore","year":"2010","journal-title":"Mamm. Genome"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","article-title":"Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice","volume":"1366","author":"Yu","year":"2010","journal-title":"Brain Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Aziz, N.M., Guedj, F., Pennings, J.L.A., Olmos-Serrano, J.L., Siegel, A., Haydar, T.F., and Bianchi, D.W. (2018). Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1\/Yey mouse models of Down syndrome. Dis. Model. Mech., 11.","DOI":"10.1242\/dmm.031013"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.celrep.2019.12.065","article-title":"Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome","volume":"30","author":"Chang","year":"2020","journal-title":"Cell Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Belichenko, P.V., Kleschevnikov, A.M., Becker, A., Wagner, G.E., Lysenko, L.V., Yu, Y.E., and Mobley, W.C. (2015). Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134861"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1523\/JNEUROSCI.2513-15.2016","article-title":"Absence of Prenatal Forebrain Defects in the Dp(16)1Yey\/+ Mouse Model of Down Syndrome","volume":"36","author":"Goodliffe","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0166-4328(98)00039-4","article-title":"Generalization of fear responses in C57BL\/6N mice subjected to one-trial fore-ground contextual fear conditioning","volume":"95","author":"Radulovic","year":"1998","journal-title":"Behav. Brain Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1074\/mcp.M113.035568","article-title":"Protein Profiles Associated with Context Fear Conditioning and Their Modulation by Memantine","volume":"13","author":"Ahmed","year":"2014","journal-title":"Mol. Cell. Proteom."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1037\/0735-7044.108.4.810","article-title":"DBA\/2 and C57BL\/6 mice differ in contextual fear but not auditory fear condi-tioning","volume":"108","author":"Paylor","year":"1994","journal-title":"Behav. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/geno.2001.6639","article-title":"Evolutionary breakpoints on human chro-mosome 21","volume":"78","author":"Davisson","year":"2001","journal-title":"Genomics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/2836","article-title":"The MAPK cascade is required for mammalian associa-tive learning","volume":"1","author":"Atkins","year":"1998","journal-title":"Nat. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ahmed, M.M., Dhanasekaran, A.R., Block, A., Tong, S., Costa, A.C., Stasko, M., and Gardiner, K.J. (2015). Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119491"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bph.12362","article-title":"Pharmacogenomics, pharmacokinetics and pharmacodynamics: Interaction with biological differ-ences between men and women","volume":"171","author":"Franconi","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jnr.23864","article-title":"Sex differences in hippocampal function","volume":"95","author":"Koss","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e00541","DOI":"10.1002\/prp2.541","article-title":"Individualized medicine: Sex, hormones, genetics, and adverse drug reactions","volume":"7","author":"Moyer","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-444-64123-6.00014-X","article-title":"Sex hormones and human brain function","volume":"175","author":"Hornung","year":"2020","journal-title":"Handb. Clin. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gall, C.M., Le, A.A., and Lynch, G. (2021). Sex differences in synaptic plasticity underlying learning. J. Neurosci. Res.","DOI":"10.1002\/jnr.24844"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.physbeh.2009.02.035","article-title":"Sex differences in learning processes of classical and operant conditioning","volume":"97","author":"Dalla","year":"2009","journal-title":"Physiol. Behav."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jnr.23809","article-title":"Understanding the broad influence of sex hormones and sex differences in the brain","volume":"95","author":"McEwen","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/ejn.14541","article-title":"Sex-dependency of oestrogen-induced structural synaptic plasticity: Inhibition of aromatase versus application of estradiol in rodents","volume":"52","author":"Brandt","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00207457909147224","article-title":"Morphological Differences in Cerebral Cortex and Corpus Callosum Are Genetically Determined in Two Different Strains of Mice","volume":"9","author":"Gozzo","year":"1979","journal-title":"Int. J. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0166-4328(05)80043-9","article-title":"Behavioural and neuroanatomical divergence between two sublines of C57BL\/6J inbred mice","volume":"42","author":"Crusio","year":"1991","journal-title":"Behav. Brain Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2788.2004.00500.x","article-title":"Sex differences in performance over 7 years on the Wechsler Intelligence Scale for Children\u2014Revised among adults with intellectual disability","volume":"48","author":"Kittler","year":"2004","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_57","first-page":"708","article-title":"A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials","volume":"6","author":"Benejam","year":"2015","journal-title":"Front. Psychol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.braindev.2017.10.001","article-title":"Developmental trend of children with Down\u2019s syndrome\u2014How do sex and neonatal conditions influence their developmental patterns?","volume":"40","author":"Aoki","year":"2018","journal-title":"Brain Dev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13293-015-0043-9","article-title":"Sex differences in protein expression in the mouse brain and their perturbations in a model of Down syndrome","volume":"6","author":"Block","year":"2015","journal-title":"Biol. Sex. Differ."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2007.05.006","article-title":"PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor","volume":"107","author":"Meyer","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"28624","DOI":"10.1074\/jbc.M201053200","article-title":"Identification of Protein Arginine Methyltransferase 2 as a Coactivator for Estrogen Receptor \u03b1","volume":"277","author":"Qi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1074\/jbc.M509260200","article-title":"SUMO-3 enhances androgen receptor transcrip-tional activity through a sumoylation-independent mechanism in prostate cancer cells","volume":"281","author":"Zheng","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/MCB.00753-12","article-title":"Dynamic SUMOylation Is Linked to the Activity Cycles of Androgen Receptor in the Cell Nucleus","volume":"32","author":"Rytinki","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-019-0457-9","article-title":"SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability","volume":"17","author":"Yang","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"ref_65","first-page":"61","article-title":"Editing of Neurotransmitter Receptor and Ion Channel RNAs in the Nervous System","volume":"Volume 353","author":"Samuel","year":"2012","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M110.200881","article-title":"Requirement of the RNA-editing Enzyme ADAR2 for Normal Physiology in Mice","volume":"286","author":"Horsch","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/jcbfm.2011.77","article-title":"Sex Differences in Neuroprotection Provided by Inhibition of TRPM2 Channels following Experimental Stroke","volume":"31","author":"Jia","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/jcbfm.2013.105","article-title":"Androgen and PARP-1 Regulation of TRPM2 Channels after Ischemic Injury","volume":"33","author":"Shimizu","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_69","first-page":"138","article-title":"Abnormal Protein Profiles in Hippocampus of Mouse Models of Down Syndrome: Similarities with Alzheimer\u2019s Disease","volume":"4","author":"Dhanasekaran","year":"2014","journal-title":"J. Alzheimer\u2019s Dis. Park."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/10\/1528\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:06:11Z","timestamp":1760166371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/10\/1528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["genes12101528"],"URL":"https:\/\/doi.org\/10.3390\/genes12101528","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]}}}